BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18295728)

  • 1. BAFF, APRIL, TWE-PRIL: who's who?
    Daridon C; Youinou P; Pers JO
    Autoimmun Rev; 2008 Feb; 7(4):267-71. PubMed ID: 18295728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution.
    Guan ZB; Shui Y; Zhang SQ
    Cytokine; 2007 Sep; 39(3):192-200. PubMed ID: 17822916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
    Mackay F; Silveira PA; Brink R
    Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
    Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J
    Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complexity of the BAFF TNF-family members: implications for autoimmunity.
    Lahiri A; Pochard P; Le Pottier L; Tobón GJ; Bendaoud B; Youinou P; Pers JO
    J Autoimmun; 2012 Sep; 39(3):189-98. PubMed ID: 22749832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.
    Le Pottier L; Sapir T; Bendaoud B; Youinou P; Shoenfeld Y; Pers JO
    Ann N Y Acad Sci; 2007 Sep; 1110():426-32. PubMed ID: 17911457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF, APRIL and their receptors: structure, function and signaling.
    Bossen C; Schneider P
    Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BAFF/APRIL system: life beyond B lymphocytes.
    Ng LG; Mackay CR; Mackay F
    Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
    Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
    Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
    Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel function of TNF cytokines in regulating bone marrow B cell survival.
    Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
    Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
    Mackay F; Schneider P
    Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
    Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
    Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An APRIL to remember: novel TNF ligands as therapeutic targets.
    Dillon SR; Gross JA; Ansell SM; Novak AJ
    Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the BAFF/APRIL system on T cell function.
    Mackay F; Leung H
    Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.
    Sutherland AP; Mackay F; Mackay CR
    Pharmacol Ther; 2006 Dec; 112(3):774-86. PubMed ID: 16863659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of APRIL and BAFF in lymphocyte activation.
    Schneider P
    Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses.
    Bossen C; Tardivel A; Willen L; Fletcher CA; Perroud M; Beermann F; Rolink AG; Scott ML; Mackay F; Schneider P
    Eur J Immunol; 2011 Mar; 41(3):787-97. PubMed ID: 21287546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.